Chris has deep expertise in the areas of process development and current goods manufacturing for vaccines and therapeutics; DNA, RNA, and protein chemistry and modeling; bacteriology; retrovirology; chemical, biological, radiological, nuclear, and explosive sensor and device development; and novel materials for detection of chemical analytes at trace (parts per billion and trillion) levels. He is well-versed in applicable guidelines from within the Code of Federal Regulations, Department of Defense technology acquisition and maturation, U.S. Food and Drug Administration application, U.S. Pharmacopeia, and the International Council for Harmonization.